Based on the structure of & rather than + in the components, does code 103633-4 Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis [Presence] in Genital fluid by NAA with probe detection represent results for each part of the component? If so, would these be better represented as panels?
Hello Jeremy and thanks for posting the question. This reporting model can be used when the users want their system to report the presence of any of the three organism or the absence of all three in one result field. Should the user want to report as a panel, the result level constituents are already present in LOINC, as well as order panels (for genital or urine sources). They would have requested an order LOINC for genital fluid possibly.
Thereās a similar tangent in Drug/Tox Drugs of Abuse reporting, where panels could be created of each drug/class in a screen OR use of the āDrugs identifiedā series vs āDrugs Tested Forā to have positives contained in the Drugs Identified and Negatives listed under Drugs Tested For.
As youāre aware thereās not a published āBest Practices of how to build a Laboratory Compendium in a Laboratory Information Systemā. If we had such an industry agreement, weād be one step closer to interoperability. My personal thought: some evaluation of how many keystrokes/time effort it takes for the bench to track the pendings and report out the work has an impact on the final design in the LIS.
1 Like
Hello Pam,
Thank you for the prompt response and your insight! Youāve cleared it up for me.